Compass Therapeutics
Clinical trials sponsored by Compass Therapeutics, explained in plain language.
-
New cancer drug CTX-10726 enters first human tests
Disease control Recruiting nowThis early-stage trial tests an experimental drug called CTX-10726 in about 70 people with advanced gastroesophageal, liver, endometrial, or kidney cancers that have stopped responding to standard treatments. The main goal is to check safety and find the right dose. Participants …
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New experimental drug CTX-8371 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage study is testing an experimental drug called CTX-8371 in people with advanced lung, breast, lymphoma, head and neck, or skin cancers that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 85 parti…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC